US Army Awards Contract to NeuroWave Systems for the Development of a Battlefield Detector for TBI Assessment (SeizTBI™)

CLEVELAND HEIGHTS, Ohio (March, 2013) - NeuroWave Systems Inc. announced today that it has been awarded an Army Rapid Innovation Fund contract for nearly $2.5 million from the US Army Medical Research and Materiel Command (USAMRMC). The program will develop a detector for Traumatic Brain Injury (TBI) Assessment (SeizTBI™), a far-forward wearable brain monitor to provide Medics with an objective early screening tool for TBI in injured warfighters, directly at the point-of-injury. The system will be a miniaturized version of its NeuroFAST™ brain monitor.

Dr. Stéphane Bibian, NeuroWave’s principal investigator stated: "The device is small, light-weight and designed for rapid deployment in austere environments. We believe the SeizTBI will become part of the Medic's medical pack to screen for a suspected concussion or TBI. The device will automatically acquire and save post-injury electroencephalogram (EEG) data, and process the signals to detect the early EEG markers of TBI. If any such pattern is detected, the device will output a visual cue to signal that the casualty is at high risk for TBI and requires follow-up care."

Robert N. Schmidt, NeuroWave’s chairman said that, "TBI accounts for about 22% of casualties in the recent conflicts in Afghanistan and Iraq. An Army Mental Health report in February 2009 indicated that 11% of 2,195 soldiers surveyed in Iraq and Afghanistan show signs of mild brain injury, but fewer than half were identified and evaluated in the field. Currently, the Army medical community lacks the means to promptly assess, diagnose, treat, and rehabilitate Soldiers who have been exposed to ballistic and blast events or other insults. The main challenge is to rapidly conduct in-the-field screening, assessment and mitigating treatment to improve short and long term adverse outcomes of mild TBI (mTBI) and TBI. This new SeizTBI will be a valuable addition to our series of products: the NeuroSENSE®, currently being sold to anesthesiologists and operating rooms in Canada and Europe; and the NeuroFAST™ and AutoTIVA™ (an "autopilot" for anesthesia), which are being developed and clinically tested. It will also be a valuable tool for emergency medical technicians and hospital emergency rooms for civilians."

About NeuroWave:
NeuroWave Systems Inc.'s mission is to develop, manufacture, and market monitoring products using advanced signal processing of brain waves (electroencephalogram - EEG) and other biosignals for Neurology, Anesthesia, Critical Care, and Emergency and Military Medicine applications, in order to improve patient outcome and quality of life.

For further information regarding NeuroWave Systems Inc., visit the Company's website at www.neurowavesystems.com.

NeuroSENSE is a registered trademark of NeuroWave Systems Inc., Cleveland Heights, Ohio.